FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 362 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Real-World Increase in Biomarker Testing in Lung Cancer Patients, Registry Study... March 23, 2022 How My Inherited Cancer Diagnosis Has Made Me a Better Oncologist February 23, 2021 OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally... August 4, 2025 Treating the Whole Person: How Cancer Centers Are Addressing Social Needs July 18, 2024 Load more HOT NEWS Born Blind With 50% Chance Of Survival, 20-Year-Old Musician Defied All... Despite Proven Safety of HPV Vaccines, More Parents Have Concerns ΚΑΡΚΙΝΟΣ ΠΝΕΥΜΟΝΑ The (un)usual suspects – how early detection research embraces interdisciplinary science
